Join the Newsletter
SEARCH
Loading
Search Filters
  • Speakers
  • Audience
  • Topic
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
15:15
  1. Roundtable: Leading through ambiguity: Finding clarity, courage and trust when there is no playbook
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    Charlotte Serra
    Charlotte Serra, President - RAPS Switzerland Chapter
  2. Roundtable: Non-linear career paths: Leveraging unique journeys
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    Cristina Salado
    Cristina Salado, Assistant Professor - Universitat Pompeu Fabra
  3. Roundtable: Founding & investment reality – what actually gets backed
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    In Partnership with Advantera
    Marisol Quintero
    Marisol Quintero, Operating Partner - Columbus Ventrue Partners
  4. Roundtable: Leadership & career progression - Breaking the invisible ceiling
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    Focus: progression into senior roles in pharma, biotech, and startups
    Azadeh Kia
    Azadeh Kia, VP Gene Therapy Research - Beacon Therapeutics
  5. Roundtable: Building & scaling in advanced Therapies - From idea to execution
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    Focus: the operational reality of building companies and careers in CGT/biotech
    Kayleigh Thirlwell
    Kayleigh Thirlwell, Senior Director - Resolution Therapeutics
  6. Roundtable: The power of community: Building your industry network
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    Focus: refine how you present your experience, expertise, and ambition
    Margot Pont
    Margot Pont, VP Translational Development - Integra Therapeutics
  7. Roundtable: Successful teams don’t happen by accident
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    In Partnership with Fresenius
    Lindsey Clarke
    Lindsey Clarke, Director Commercialization Therapeutic Apheresis & Cell Therapy - Fresenius Kabi
  8. Roundtable: Unleash your inner crone
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    Leila Abbas
    Leila Abbas, Preclinical Lead - Rinri Therapeutics
16:15
  1. Closing statement. From insight to action: What happens next?
    Workshop Room (Rossini 1&2)
    15 mins
    • Women in Advanced Therapies Congress
     
    Becky Johnson-Kent
    Becky Johnson-Kent, Managing Director, WiAT - Phacilitate
18:30
  1. Cocktails by Sunset
    SUPERLOCAL
    90 mins
    • Networking Break
    Join our annual kick-off welcome party taking place at sunset! Sponsored by Gift of Life Biologics
08:00
  1. Registration & Networking
    Gebre Hall
    60 mins
    • Networking Break
    Registration Sponsored by Catalent
09:00
  1. Welcome Address
    Theatre 1&2 (Rubi & Zafir)
    5 mins
    • Plenary
     
09:05
  1. Keynote Presentation: Regulatory principles shaping the future of advanced therapies
    Theatre 1&2 (Rubi & Zafir)
    10 mins
    • Plenary
     
    Jacob George
    Jacob George, Chief Medical & Scientific Officer - MHRA
09:15
  1. Panel: Europe’s ATMP rulebook reset: The 12-month pathway from fragmented rules to trusted EU execution
    Theatre 1&2 (Rubi & Zafir)
    35 mins
    • Plenary
    From legislation to execution: What ATMP developers must change now in regulatory, CMC and evidence planning to stay aligned with EU reform over the next 12 months. Fixing fragmentation where it hurts ...
    Esteve Trias
    Esteve Trias, ATMP Expert
    Jacob George
    Jacob George, Chief Medical & Scientific Officer - MHRA
    Robert Allen
    Robert Allen, Chief Business Officer - Dark Horse Consulting
    Sean Russell
    Sean Russell, Head of Regulatory Affairs - Fondazione Telethon
09:50
  1. Panel: Europe’s Roadmap Winning the Next Wave of ATMP R&D: What Europe must resolve to compete on speed, scale and return
    Theatre 1&2 (Rubi & Zafir)
    40 mins
    • Plenary
    Speed breaks first: Why Europe still loses ATMP programmes at the trial-start and scale-up stages and what can be fixed in the next 12 months around approvals, site readiness and cross-border trial ex ...
    Bo Wiinberg
    Bo Wiinberg, CBO - Novo Nordisk Foundation Cellerator
    Jacqueline Barry
    Jacqueline Barry, Chief Clinical Officer - Cell and Gene Therapy Catapult
    Jim Lund
    Jim Lund, Chief Business Development Officer - CCRM Nordic
    Miguel Forte
    Miguel Forte, CEO - Kiji Therapeutics
    Montse Daban
    Montse Daban, Director of Strategic Foresight and International Relations - BIOCAT
    Paolo Morgese
    Paolo Morgese, Vice President Public Affairs, Europe - Alliance for Regenerative Medicine
10:30
  1. Break
    Exhibition Hall
    45 mins
    • Networking Break
     
11:15
  1. Fireside chat: Data that holds up under pressure: How to generate Phase I–II efficacy data that survives scale-up, scrutiny and value inflection
    Theatre 1 (Zafir)
    30 mins
    • Cell & Gene Therapy Clinical Pathways
    Efficacy data as a scaling input, not an endpoint: How Phase I expansion and Phase II data should actively inform tech transfer, manufacturing readiness and comparability so scale-up and fundraising d ...
    Azadeh Kia
    Azadeh Kia, VP Gene Therapy Research - Beacon Therapeutics
    Judith Koliwer
    Judith Koliwer, Senior Industry Advisor and Principal Consultant Advanced Therapies - Körber Pharma
    Kieran Breen
    Kieran Breen, Data and Innovation Steering Group - Parkinson's Europe
    Nina Kotsopoulou
    Nina Kotsopoulou, CTO - AAVantgarde
  2. Spotlight: Slay the vial dragon – Solving the ATMP vial fill bottleneck to drive high-efficiency production
    Theatre 2 (Rubi)
    15 mins
    • Operational & Commercial Performance
     
    Chao Sheng
    Chao Sheng, Director, Process & Analytical Development - CCRM Nordic
    David Kneen
    David Kneen, CEO - Celleo
Loading
Search Filters
  • Speakers
  • Audience
  • Topic
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
15:15
  1. Roundtable: Leading through ambiguity: Finding clarity, courage and trust when there is no playbook
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    Charlotte Serra
    Charlotte Serra, President - RAPS Switzerland Chapter
  2. Roundtable: Non-linear career paths: Leveraging unique journeys
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    Cristina Salado
    Cristina Salado, Assistant Professor - Universitat Pompeu Fabra
  3. Roundtable: Founding & investment reality – what actually gets backed
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    In Partnership with Advantera
    Marisol Quintero
    Marisol Quintero, Operating Partner - Columbus Ventrue Partners
  4. Roundtable: Leadership & career progression - Breaking the invisible ceiling
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    Focus: progression into senior roles in pharma, biotech, and startups
    Azadeh Kia
    Azadeh Kia, VP Gene Therapy Research - Beacon Therapeutics
  5. Roundtable: Building & scaling in advanced Therapies - From idea to execution
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    Focus: the operational reality of building companies and careers in CGT/biotech
    Kayleigh Thirlwell
    Kayleigh Thirlwell, Senior Director - Resolution Therapeutics
  6. Roundtable: The power of community: Building your industry network
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    Focus: refine how you present your experience, expertise, and ambition
    Margot Pont
    Margot Pont, VP Translational Development - Integra Therapeutics
  7. Roundtable: Successful teams don’t happen by accident
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    In Partnership with Fresenius
    Lindsey Clarke
    Lindsey Clarke, Director Commercialization Therapeutic Apheresis & Cell Therapy - Fresenius Kabi
  8. Roundtable: Unleash your inner crone
    60 mins
    • Women in Advanced Therapies Congress
    • Roundtable
    Leila Abbas
    Leila Abbas, Preclinical Lead - Rinri Therapeutics
16:15
  1. Closing statement. From insight to action: What happens next?
    Workshop Room (Rossini 1&2)
    15 mins
    • Women in Advanced Therapies Congress
     
    Becky Johnson-Kent
    Becky Johnson-Kent, Managing Director, WiAT - Phacilitate
18:30
  1. Cocktails by Sunset
    SUPERLOCAL
    90 mins
    • Networking Break
    Join our annual kick-off welcome party taking place at sunset! Sponsored by Gift of Life Biologics
08:00
  1. Registration & Networking
    Gebre Hall
    60 mins
    • Networking Break
    Registration Sponsored by Catalent
09:00
  1. Welcome Address
    Theatre 1&2 (Rubi & Zafir)
    5 mins
    • Plenary
     
09:05
  1. Keynote Presentation: Regulatory principles shaping the future of advanced therapies
    Theatre 1&2 (Rubi & Zafir)
    10 mins
    • Plenary
     
    Jacob George
    Jacob George, Chief Medical & Scientific Officer - MHRA
09:15
  1. Panel: Europe’s ATMP rulebook reset: The 12-month pathway from fragmented rules to trusted EU execution
    Theatre 1&2 (Rubi & Zafir)
    35 mins
    • Plenary
    From legislation to execution: What ATMP developers must change now in regulatory, CMC and evidence planning to stay aligned with EU reform over the next 12 months. Fixing fragmentation where it hurts ...
    Esteve Trias
    Esteve Trias, ATMP Expert
    Jacob George
    Jacob George, Chief Medical & Scientific Officer - MHRA
    Robert Allen
    Robert Allen, Chief Business Officer - Dark Horse Consulting
    Sean Russell
    Sean Russell, Head of Regulatory Affairs - Fondazione Telethon
09:50
  1. Panel: Europe’s Roadmap Winning the Next Wave of ATMP R&D: What Europe must resolve to compete on speed, scale and return
    Theatre 1&2 (Rubi & Zafir)
    40 mins
    • Plenary
    Speed breaks first: Why Europe still loses ATMP programmes at the trial-start and scale-up stages and what can be fixed in the next 12 months around approvals, site readiness and cross-border trial ex ...
    Bo Wiinberg
    Bo Wiinberg, CBO - Novo Nordisk Foundation Cellerator
    Jacqueline Barry
    Jacqueline Barry, Chief Clinical Officer - Cell and Gene Therapy Catapult
    Jim Lund
    Jim Lund, Chief Business Development Officer - CCRM Nordic
    Miguel Forte
    Miguel Forte, CEO - Kiji Therapeutics
    Montse Daban
    Montse Daban, Director of Strategic Foresight and International Relations - BIOCAT
    Paolo Morgese
    Paolo Morgese, Vice President Public Affairs, Europe - Alliance for Regenerative Medicine
10:30
  1. Break
    Exhibition Hall
    45 mins
    • Networking Break
     
11:15
  1. Fireside chat: Data that holds up under pressure: How to generate Phase I–II efficacy data that survives scale-up, scrutiny and value inflection
    Theatre 1 (Zafir)
    30 mins
    • Cell & Gene Therapy Clinical Pathways
    Efficacy data as a scaling input, not an endpoint: How Phase I expansion and Phase II data should actively inform tech transfer, manufacturing readiness and comparability so scale-up and fundraising d ...
    Azadeh Kia
    Azadeh Kia, VP Gene Therapy Research - Beacon Therapeutics
    Judith Koliwer
    Judith Koliwer, Senior Industry Advisor and Principal Consultant Advanced Therapies - Körber Pharma
    Kieran Breen
    Kieran Breen, Data and Innovation Steering Group - Parkinson's Europe
    Nina Kotsopoulou
    Nina Kotsopoulou, CTO - AAVantgarde
  2. Spotlight: Slay the vial dragon – Solving the ATMP vial fill bottleneck to drive high-efficiency production
    Theatre 2 (Rubi)
    15 mins
    • Operational & Commercial Performance
     
    Chao Sheng
    Chao Sheng, Director, Process & Analytical Development - CCRM Nordic
    David Kneen
    David Kneen, CEO - Celleo
Search